We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+10.47%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$2.94B
AUM Growth
+$184M
Cap. Flow
-$79.5M
Cap. Flow %
-2.7%
Top 10 Hldgs %
42.7%
Holding
135
New
34
Increased
27
Reduced
33
Closed
29

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$53.9M
2
ORLY icon
O'Reilly Automotive
ORLY
+$41M
3
BIIB icon
Biogen
BIIB
+$40.8M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$36.6M
5
ULTA icon
Ulta Beauty
ULTA
+$35M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$57.2M
2
MRK icon
Merck
MRK
+$43.5M
3
WSM icon
Williams-Sonoma
WSM
+$40.2M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$38.7M
5
LOW icon
Lowe's Companies
LOW
+$34.2M

Sector Composition

Rank Sector Weight
1 Healthcare 48.15%
2 Consumer Staples 11.86%
3 Consumer Discretionary 11.13%
4 Technology 1.98%
5 Industrials 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRX
26
DELISTED
Catalyst Pharmaceutical
CPRX
$33.4M 1.14%
10,000,000
– –
FTDR icon
27
Frontdoor
FTDR
$5.39B
$32.9M 1.12%
656,000
-216,000
-25% -$9.87M
KO icon
28
Coca-Cola
KO
$372B
$32.9M 1.12%
600,000
-48,000
-7% -$2.48M
SPPI
29
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$32.7M 1.11%
9,592,000
+2,020,000
+27% +$8.31M
AZO icon
30
AutoZone
AZO
$49.4B
$32.7M 1.11%
27,589
-23,702
-46% -$27.4M
TGT icon
31
Target
TGT
$67.3B
$31.5M 1.07%
+178,687
New +$29.8M
NUVA
32
DELISTED
NuVasive, Inc.
NUVA
$30.4M 1.03%
540,000
+90,000
+20% +$4.43M
MDT icon
33
Medtronic
MDT
$110B
$30M 1.02%
256,000
-172,000
-40% -$18.9M
BGS icon
34
B&G Foods
BGS
$289M
$29.5M 1%
+1,064,000
New +$30M
ROST icon
35
Ross Stores
ROST
$80.5B
$26.1M 0.89%
212,284
-227,716
-52% -$23.9M
BURL icon
36
Burlington
BURL
$23.2B
$25.5M 0.87%
+97,443
New +$21.7M
VYGR icon
37
Voyager Therapeutics
VYGR
$189M
$24.3M 0.82%
3,392,000
+692,000
+26% +$6.65M
BABA icon
38
Alibaba
BABA
$309B
$24.2M 0.82%
+104,000
New +$28.9M
DXCM icon
39
DexCom
DXCM
$32.8B
$23.7M 0.8%
+256,000
New +$22.9M
ARGX icon
40
argenx
ARGX
$52.8B
$23.5M 0.8%
80,000
-5,000
-6% -$1.37M
TWNK
41
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$23.1M 0.79%
1,578,000
-546,000
-26% -$7.35M
MDLZ icon
42
Mondelez International
MDLZ
$79.2B
$22.9M 0.78%
392,000
-4,000
-1% -$229K
ZYME icon
43
Zymeworks
ZYME
$1.68B
$21.3M 0.72%
450,000
-266,000
-37% -$12.4M
AVTA
44
DELISTED
Avantax, Inc. Common Stock
AVTA
$21.1M 0.72%
1,328,000
-1,672,000
-56% -$20.4M
BNTX icon
45
BioNTech
BNTX
$23.1B
$19.2M 0.65%
236,000
-100,000
-30% -$9.82M
BIO icon
46
Bio-Rad Laboratories Class A
BIO
$8.91B
$19.2M 0.65%
33,000
+13,000
+65% +$7.4M
DKS icon
47
Dick's Sporting Goods
DKS
$18B
$18.7M 0.64%
332,389
-87,611
-21% -$4.99M
ILMN icon
48
Illumina
ILMN
$30.7B
$18.5M 0.63%
+51,400
New +$16.4M
TMO icon
49
Thermo Fisher Scientific
TMO
$209B
$18.2M 0.62%
39,000
+23,000
+144% +$10.8M
BSX icon
50
Boston Scientific
BSX
$71.1B
$18M 0.61%
+500,000
New +$18M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Armistice Capital held 135 positions worth $2.94B, up 6.7% from $2.76B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Armistice Capital's Q4 2020 filing shows 34 new, 27 increased, 33 reduced and 29 closed positions. Its largest new stake was Walmart Inc: 1,110,675 shares worth $53.4M. The largest sale was Alexion Pharmaceuticals, an estimated $57.2M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q4 2020 buy was Walmart Inc: 1,110,675 shares worth $53.4M.
  • Armistice Capital added most to Biogen in Q4 2020, an estimated $40.8M increase.
  • Armistice Capital's biggest Q4 2020 reduction was Energizer, cutting an estimated $29.6M.
  • Armistice Capital fully exited Alexion Pharmaceuticals in Q4 2020, selling an estimated $57.2M.
  • Armistice Capital's ten largest holdings make up 43% of its $2.94B portfolio in Q4 2020.
  • Armistice Capital opened 34 new positions and closed 29 in Q4 2020.
  • Armistice Capital's portfolio value rose 6.7% quarter-over-quarter to $2.94B.

Based on Armistice Capital's 13F filing for Q4 2020, filed 16 Feb 2021.